Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $65,625 | 6 | 84.2% |
| Travel and Lodging | $11,939 | 6 | 15.3% |
| Food and Beverage | $354.95 | 10 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $45,869 | 18 | $0 (2024) |
| Ipsen Bioscience Inc. | $15,300 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $13,875 | 1 | $0 (2024) |
| Corcept Therapeutics | $2,850 | 1 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.42 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,451 | 8 | GlaxoSmithKline, LLC. ($22,251) |
| 2023 | $23,618 | 13 | GlaxoSmithKline, LLC. ($23,618) |
| 2020 | $2,850 | 1 | Corcept Therapeutics ($2,850) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $13,875.00 | General |
| 02/13/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| 02/13/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $627.30 | General |
| 02/13/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $16.61 | General |
| 02/13/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| 01/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,600.00 | General |
| 01/19/2024 | Ipsen Bioscience Inc. | — | Consulting Fee | Cash or cash equivalent | $15,300.00 | General |
| 12/04/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| 12/04/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $627.30 | General |
| 12/04/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $16.61 | General |
| 12/04/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $7.36 | General |
| 11/10/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $1,433.51 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $94.55 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $65.03 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $43.68 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $41.76 | General |
| 06/25/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $9,217.50 | General |
| 06/25/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $52.59 | General |
| 06/25/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $9.10 | General |
| 06/25/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $9.10 | General |
| 06/19/2020 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 52 | $15,420 | $5,756 |
| 2022 | 1 | 11 | 11 | $2,167 | $50.40 |
| 2021 | 1 | 14 | 45 | $11,250 | $3,976 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 41 | $10,250 | $4,138 | 40.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,170 | $1,618 | 31.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 11 | 11 | $2,167 | $50.40 | 2.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 45 | $11,250 | $3,976 | 35.3% |
About Dr. Pei Lim Lee, M.D
Dr. Pei Lim Lee, M.D is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982947131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pei Lim Lee, M.D has received a total of $77,919 in payments from pharmaceutical and medical device companies, with $51,451 received in 2024. These payments were reported across 22 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($65,625).
As a Medicare-enrolled provider, Lee has provided services to 49 Medicare beneficiaries, totaling 108 services with total Medicare billing of $9,783. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Transplant Hepatology, Gastroenterology
- Location Los Angeles, CA
- Active Since 04/05/2013
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982947131
Products in Payments
- Korlym (Drug) $2,850
- XIFAXAN (Drug) $24.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666